Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Astrid Weins

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Kidney International Reports|April 30, 2025
An Exosomal mRNA Urine Test for Detection and Risk Stratification of Human Kidney Transplant RejectionRania El Fekih, Kurt Franzen, James Hurley, et al.
The New England Journal of Medicine|May 28, 2024
Autoantibodies Targeting Nephrin in PodocytopathiesFelicitas E Hengel, Silke Dehde, Moritz Lassé, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2020
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemicMaria Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
Cell Reports|May 23, 2024
Protective role for kidney TREM2<sup>high</sup> macrophages in obesity- and diabetes-induced kidney injuryAyshwarya Subramanian, Katherine A Vernon, Yiming Zhou, et al.
The Journal of Clinical Investigation|December 16, 2024
Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptorsSilvana Bazua-Valenti, Matthew R Brown, Jason Zavras, et al.
Cell Reports. Medicine|December 9, 2020
A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung InjuryMaria Kost-Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
Kidney International|August 14, 2022
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancerShruti Gupta, Ian A Strohbehn, Qiyu Wang, et al.
Cell|July 27, 2019
Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse ProteinopathyMoran Dvela-Levitt, Maria Kost-Alimova, Maheswarareddy Emani, et al.
Kidney International|December 14, 2023
Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosisTereza Kmochová, Kendrah O Kidd, Andrew Orr, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Kidney International Reports|April 30, 2025
An Exosomal mRNA Urine Test for Detection and Risk Stratification of Human Kidney Transplant RejectionRania El Fekih, Kurt Franzen, James Hurley, et al.
The New England Journal of Medicine|May 28, 2024
Autoantibodies Targeting Nephrin in PodocytopathiesFelicitas E Hengel, Silke Dehde, Moritz Lassé, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2020
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemicMaria Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
Cell Reports|May 23, 2024
Protective role for kidney TREM2<sup>high</sup> macrophages in obesity- and diabetes-induced kidney injuryAyshwarya Subramanian, Katherine A Vernon, Yiming Zhou, et al.
The Journal of Clinical Investigation|December 16, 2024
Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptorsSilvana Bazua-Valenti, Matthew R Brown, Jason Zavras, et al.
Cell Reports. Medicine|December 9, 2020
A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung InjuryMaria Kost-Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
Kidney International|August 14, 2022
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancerShruti Gupta, Ian A Strohbehn, Qiyu Wang, et al.
Cell|July 27, 2019
Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse ProteinopathyMoran Dvela-Levitt, Maria Kost-Alimova, Maheswarareddy Emani, et al.
Kidney International|December 14, 2023
Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosisTereza Kmochová, Kendrah O Kidd, Andrew Orr, et al.
Pageof 8